Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Myles D. Greenberg | M | 56 |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
James Corbett | M | 65 |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Daniel Pelak | M | 72 |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | 6 jaar |
David Flicek | M | - |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Ryan Hansen | M | - |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Julie Lautt | F | - |
Alucent Biomedical Inc.
Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Alucent Biomedical Inc. operates as a biomedical company. It focuses on transforming the way vascular disease is treated by which natural vascular scaffolding (NVS) is a breakthrough technology developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). The company is headquartered in Salt Lake City, UT. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 6 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Pat Costello
- Persoonlijk netwerk